980 drugs of 144 companies faced with 9.99% price slash.

Published: 2003-08-22 06:59:00

Updated: 2003-08-22 06:59:00

The government post-supervision over the actual transaction drug prices in the markets brought out a massive NHI reimbursement price slash, in maximum up to 9.99% for 980 drugs supplied by 144 companies.

The supervision report revealed that 41 companies faced with price slashes for over 10 dru...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK